Evangelia Vlachou, MD

Evangelia Vlachou, MD, is a postdoctoral research fellow in the Departments of Medical Oncology and Urology at Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins.

Articles by Evangelia Vlachou, MD

Evangelia Vlachou, MD, postdoctoral research fellow, Departments of Medical Oncology and Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins

Dr Vlachou on the Rationale for Evaluating Perioperative Enfortumab Vedotin Plus Pembrolizumab in Upper Tract Urothelial CancerCancer

ByEvangelia Vlachou, MD

May 16th 2025

Evangelia Vlachou, MD, discusses the investigation of enfortumab vedotin plus pembrolizumab as perioperative therapy in upper tract urothelial cancer.

Dr Vlachou on Primary Tumor Responses With Enfortumab Vedotin in Upper Tract Urothelial Cancer

ByEvangelia Vlachou, MD

March 4th 2025

Evangelia Vlachou, MD, discusses response rates with enfortumab vedotin alone or with pembrolizumab in patients with upper tract urothelial cancer.

Evangelia Vlachou, MD

Articles by Evangelia Vlachou, MD

Dr Vlachou on the Rationale for Evaluating Perioperative Enfortumab Vedotin Plus Pembrolizumab in Upper Tract Urothelial CancerCancer

Dr Vlachou on Primary Tumor Responses With Enfortumab Vedotin in Upper Tract Urothelial Cancer

Latest Updated Articles

Trending on OncLive

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies

FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma

Oncology Fellows Highlights 2025 ESMO Fellowship Winners